Pascal Winnen newly elected Member of the Board of Directors
Beatrix Benz joining Advancience’s Scientific & Advisory Board
Allschwil, November 8, 2019
During an extraordinary Shareholder Meeting of Advancience Ltd., shareholders elected Pascal Winnen as a new Member of the Board of Directors. Pascal is the CEO of HEMEX, a company that provides consultancy and investment services on a senior executive level to the pharmaceutical, medtech and veterinary industry. He also is a member of the board of directors of several companies in these industries.
Beatrix Benz will join the Advancience Scientific & Advisory Board. Beatrix has more than 15 years of experience in all aspects of Corporate Communications and Public Affairs in the Healthcare and Life Sciences sectors. A scientist by training, she has worked extensively with big pharma, speciality pharma and biotech, and held key communications roles with AC Immune, Vifor Pharma, Nycomed and Novartis. Beatrix is the Founder and Managing Partner of Benz Advisory and a Partner at Healthcare Shapers.